Price Table
| Date | Open | High | Low | Close | Volume | Delivery % | 20-Day sma | 50-Day sma | 200-Day sma |
|---|
View More
Day High Low Range
| Time | Lowest | Highest | Volume |
|---|
Past Performance & Moving Averages
| Day’s | Low high range | SMA | Stock performance | Nifty performance |
|---|
PIVOT POINTS
| NAME | S4 | S3 | S2 | S1 | PIVOT POINTS | R1 | R2 | R3 | R4 |
|---|---|---|---|---|---|---|---|---|---|
| CLASSIC | - | - | - | - | - | - | - | - | - |
| WOODIE‘S | - | - | - | - | |||||
| FIBONACCI | - | - | |||||||
| CAMARILLA | - |
Trend Analysis
Key Data
| Market cap | Book value | stock p/e | Dividend yield | roce | roe | sales growth (3Y) | face value (3Y) |
|---|
Profile
Founder:
Founded: 1973
Headquarters: Mumbai
No. of Employees: 6500+
PRODUCTS
Branded Generic/ Formulation/ Medicine
PROFILE
The Company based on the development, Manufacturing, and Marketing of Pharmaceutical Formulation.
Presence in India, U.S, 30 other countries in Africa, Asia, the Middle East, and CIS
SUBSIDIARIES
Ajanta Pharma (Mauritius)
Ajanta Pharma (Phillippines)
Ajanta Pharma (U.S.A)
Ajanta Pharma (Nigeria)
MILESTONE
2000: The Company was noted as a major source of forcing currency alongside Reddy Labs, Sales from Southeast Asia.
2003: A Joint venture between Ajanta and the Health Ministry of Turkmenistan
A Joint venture with regional government such as Uzbekistan, Kazakhstan, Kyrgyzstan and Tajikistan
2005: The Company experienced an enormous loss in terms of diminution of value.
2005: The Company noted as having the highest sale in India with sales of 13.56 Million.
2015: The Company was Highlighted as having an exceptional stock appreciation and listing of stock on BSE 500
2019: Stock was listed on the S and P BSE 200 Index.
Trading and Investment Terminology